You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 4, April 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Cutaneous Amyloidoses

Pathogenesis and Therapy

Stephen M. Breathnach, MA, MD, MRCP

Arch Dermatol. 1985;121(4):470-475.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The term amyloidosis refers to the extracellular deposition of an abnormal protein material with characteristic tinctorial properties and ultrastructural features.1 Under the electron microscope, amyloid deposits consist largely of a loose network of 7.5 to 10-nm rigid, linear, nonbranching, aggregated, paired fibrils of indefinite length and with hollow cores on profile.2 Infrared spectroscopy and X-ray diffraction crystallography have revealed that amyloid fibrils are usually composed of polypeptide chains arranged perpendicularly to the long axis of the fibril with the conformation of a meridional, antiparallel, β-pleated sheet.3,4 During the course of purification of extracted amyloid fibril preparations, a further amyloid tissue protein, quite separate from the fibrillar component of amyloid deposits, was identified.5 This novel amyloid tissue protein, termed amyloid P (plasma) component (AP) because of its antigenic identity to an {alpha}-globulin in the blood of normal individuals,6 may represent up to 14% by weight of extracted amyloid material.1 . . . [Full Text PDF of this Article]


Author Affiliations

Bethesda, Md



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.